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Summary 
 
 Eighty-five pigs (initially 12.9 lb and 15 
±1 d of age) were used in two 28-d trials to 
determine the effects of the probiotics BioPlus 
2B (a bacillus-based product from Chr. Han-
sen BioSystems), a source of Bacillus subtilis 
and Bacillus licheniformis, and Levucell SB 
(an active dry yeast product from Lallemand 
Animal Nutrition), a yeast (Saccharomyces 
cerevisiae) product that is a source of man-
nanoligosaccharides on growth and perform-
ance of Salmonella enterica serovar Typhi-
murium shedding in a young growing pig 
model. 
 
 Pigs were fed one of five dietary treat-
ments: 1) A control diet containing no probiot-
ics or antibiotics; 2) the control diet with car-
badox (50 g/ton); 3) the control diet with Bio-
Plus 2B (0.05% of the diet); 4) the control diet 
with Levucell SB (100 g/ton); 5) the control 
diet with Bioplus 2B (0.05% of the diet) and 
Levucell SB (100 g/ton).  Diets did not con-
tain growth promoting levels of zinc oxide or 
copper sulfate. 
 
 Significant differences in the two trials 
were seen, with the second trial having 0.1 
lb/d greater growth and .18 lb/d greater feed 
intake than the first trial.  In trial 1, pigs fed 
the control diet and Bioplus 2B had greater 
gains and feed intakes (P<0.05 and P<0.02 
respectively) than those fed carbadox.  In trial 
two, pigs fed carbadox had better performance 
than those fed the control and combination 
diets, with the BioPlus 2B and Levucell SB 
treatments having intermediate growth and 
feed intake.  Fecal shedding rates of salmo-
nella were not different (P>0.10) between di-
ets.  Results indicate that within an environ-
ment where enteric disease may be active, 
BioPlus 2B and Levucell SB may provide 
growth enhancement over a diet devoid of an-
timicrobials. 
 
(Key Words: Weanling Pigs, Disease Chal-
lenge, Salmonella, BioPlus 2B, and Sac-
charomyces cerevisiae) 
 
Introduction 
 
 With greater consumer concerns over anti-
biotic resistance, there has been increased 
pressure to remove and find alternatives to 
antibiotics in livestock diets Alternatives to 
antimicrobials that may hold promise include 
probiotic feed additives.  Supplementation of 
swine diets with probiotics to alter the intesti-
nal microbial population and to promote gut 
health has shown variable responses in 
growth.  Possible reasons for variation among 
trials may be due to various levels and species 
of enteric organisms within production sys-
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tems.  Weanling pigs were fed the probiotics 
Bioplus 2B, a bacillus-based product, and Le-
vucell SB, an active yeast culture, in order to 
determine the growth responses and bacterial 
shedding rates in the presence of an orally 
administered enteric pathogenic challenge.  
 
Materials and Methods 
 
 The Kansas State University Institutional 
Animal Care and Use Committee approved 
the experimental protocol used in this study.  
Eighty-five weanling pigs (initially 12.9 lb) 
were blocked by initial weight and allotted to 
one of five dietary treatments in two 28 d tri-
als.  Two pigs were assigned to a pen, with a 
total of eight or nine replicates per treatment.  
All pigs were housed in two environmentally 
controlled rooms.  One feeder and one nipple-
waterer were provided in each pen to allow ad 
libitum access to feed and water.  All pigs 
were fed a common diet for the first 7 d after 
weaning. The pigs were switched to the ex-
perimental dietary treatments for 14 d before 
inoculation.  The basal diet contained no 
added antimicrobials, while the positive con-
trol diet contained carbadox (50 g/ton). The 
three test diets contained a bacillus-based 
product (BioPlus 2B, Chr. Hansen BioSys-
tems; 0.05% of the diet), an active dry yeast 
product (Levucell SB, Lallemand Animal Nu-
trition; 100 g/ton), and a combination of the 
two products. The experimental diets were fed 
in meal form (Table 1). 
 
 Prior to challenge, fecal samples were 
taken to insure that all animals were not shed-
ding salmonellae organisms.  On d 14, pigs 
were inoculated with Salmonella enterica se-
rovar Typhimurium (2.36 × 106 and 1.22 x 106 
CFU in trials 1 and 2, respectively). This dose 
was used to closely mimic a chronic, but con-
tainable gut pathogen load.  Rectal tempera-
tures and feed intakes were determined daily 
for the first week after inoculation.  Pigs were 
weighed and ADFI, ADG, and F/G were de-
termined on days 0, 7, 14, 21, and 28 of the 
experimental period.  Fecal samples were col-
lected on d 21 and 28 days to be cultured for 
semi-quantitative counts of salmonellae. 
 
Table 1.  Diet Compositionab (As-fed) 
Ingredients     Control 
Corn 50.74 
Soybean meal 27.94 
Spray dried whey 10.00 
Select menhaden fishmeal 4.50 
Soy oil 3.00 
Monocalcium phosphate, 21% P 1.20 
Limestone 0.68 
Salt 0.35 
Vitamin premix 0.25 
Trace mineral premix 0.15 
Lysine HCl 0.15 
DL-Methionine 0.05 
Cornstarchb 1.00 
Total 100.00%
 
Calculated analysis  
   Lysine, % 1.39%
   ME, kcal/kg 3388 
   Calcium, % 0.90 
   Phosphorous, % 0.79 
aDiets did not contain growth promoting lev-
els of zinc oxide or copper sulfate. 
bTest ingredients, carbadox (50 g/ton), Bio-
Plus 2B (0.05% of the diet), and Levucell SB 
(100 g/ton) replaced cornstarch to provide 
the additional dietary treatment.  
 
 A semi-quantitative method for evaluating 
Salmonella shedding was developed for the 
experiment.  Salmonella growth was classified 
into one of four categories; 1) confluent 
growth over the entire agar plate (score 3); 2) 
any number of wells with growth on the agar 
plate (score 2); 3) only growth that was ob-
tained on enrichment (score 1); 4) or no 
growth detected (score 0). The shedding and 
colonization scores were analyzed using the 
non-parametric Kruskal-Wallis Test. On d 27 
and 28 of the study pigs were euthanized and 
fecal samples from the colon were collected 
and tested for the presence of culturable Sal-
monella. 
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 Data were analyzed in a randomized com-
plete block design replicated over time using 
the Mixed model procedures of SAS. All 
means presented are least-square means. 
 
Results and Discussion 
 
 Both trials are reported separately due to 
significant trial differences (P<0.05) for all 
variables except feed efficiency, and diet x 
trial interactions (P<0.05) for all variables ex-
cept feed efficiency and daily rectal tempera-
tures. 
 
Growth Performance 
 
 Trial 1.  No differences in ADG or ADFI 
were seen in the two weeks prior to challenge 
(Figure 1, left panels).  In the two weeks fol-
lowing challenge the pigs fed the control diet 
or Bioplus 2B diet had greater ADG than pigs 
fed the antibiotic or Levucell diets (P<0.01).  
Pigs fed the diet containing the combination of 
Bioplus 2B and Levucell had decreased ADG 
compared to the control pigs (P>0.03), but not 
with the pigs fed the diet containing Levucell 
(P<0.06).  Greater feed intakes were observed 
for the pigs fed the control diet and diet con-
taining Bioplus 2B compared to the pigs fed 
carbadox, Levucell, or the combination treat-
ment (P<0.03).  For the overall trial, pigs fed 
the control and Bioplus 2B diets had greater 
ADG and ADFI than the pigs fed carbadox, 
with the pigs fed Levucell and the combina-
tion being intermediate in ADG (P<0.03) and 
ADFI (P<0.02). No differences were observed 
in feed efficiency.  
 
 Growth performance in the first trial was 
surprising in that pigs fed carbadox gained 
more slowly than control pigs.  No obvious 
reasons for this effect could be identified. Ini-
tially it was hypothesized that the carbadox 
and control diets may have been accidentally 
switched at the feed mill.  However, upon 
analysis of the diets at a commercial labora-
tory, it was determined that the carbadox diet 
did indeed contain the antimicrobial at the ap-
propriate level and the negative control con-
tained no antimicrobials. At present we don’t 
have an explanation for the failure of carbadox 
to improve growth performance compared 
with control pigs.  Pigs fed the Bioplus 2B 
diets performed similarly to the pigs fed the 
control diet, with the Levucell and combina-
tion fed pigs performing intermediate in re-
sponse to enteric challenge.  The combination 
of the two probiotics showed no additive 
benefit before or after enteric challenge. 
 
 Trial 2.  Pigs fed carbadox had greater 
ADG (P<0.05) and ADFI (P<0.04) when 
compared to the pigs fed the control, Bioplus 
2B, and combination diets prior to challenge 
(Figure 1, right panels).  Pigs fed the diet con-
taining Levucell had intermediate ADG 
(P<0.07) and ADFI (P<0.04) in comparison to 
carbadox and control, Bioplus 2B, or the com-
bination diets.  In the 2 weeks following bac-
terial challenge pigs fed the diet containing 
carbadox had greater ADG than pigs fed the 
control diet (P<0.01), with the Bioplus 2B, 
Levucell, and combination fed pigs intermedi-
ate in growth (P<0.40).  Following challenge, 
carbadox-fed pigs had greater feed intakes 
than the control or combination-fed pigs (P< 
0.01).  The Bioplus 2B and Levucell-fed pigs 
were also higher (P<0.05) in feed intake than 
the control.  Overall, carbadox-fed pigs had 
greater growth than the control (P<0.01) and 
combination diets (P<0.05), with pigs fed 
Bioplus 2B (P<0.09) and Levucell having in-
termediate performance (P<0.12).  Overall in 
trial 2, the carbadox fed pigs had greater 
(P<0.02) feed intake than the control or com-
bination pigs.  The Bioplus 2B and Levucell 
fed pigs were intermediate in intake. There 
were no differences in feed efficiency. 
 
 The increase in feed intake and growth 
when feeding carbadox both before and after 
enteric challenge is consistent with several 
previous research trials in our laboratory.  
Bioplus 2B and Levucell SB pigs were inter-
mediate in growth and feed intake in compari-
son to the control and carbadox-treated pigs.  
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Although neither Levucell nor Bioplus 2B 
treatments matched carbadox in growth re-
sponse, both did numerically, though not sig-
nificantly, better than the control fed pigs.  
The combination of Bioplus 2B and Levucell 
showed no additive benefit before or after 
challenge. 
 
Fecal Salmonella Shedding Scores 
 
 Fecal Salmonella were cultured and meas-
ured 7 and 14 d following challenge with Sal-
monella serotype Typhimurium (corresponds 
to d 21 and 28 of trials). Pen shedding scores 
did not differ between treatments and were 
low and variable between days and trials, gen-
erally ranging between scores of 0 and 1 
among treatments. 
 
 Initially it was hypothesized that fecal 
scores would be lowest for carbadox treated 
pigs, with the Bioplus 2B and Levucell being 
intermediate.  Our hypothesis was based on 
the ability of antimicrobials to inhibit the 
growth of pathogenic organisms within the 
gut. Throughout both trials, fecal scores were 
typically low for presence of Salmonella for 
days 21 and 28 of the trials. No obvious 
treatment differences were observed. 
 
Summary 
 
 Growth performance and feed intake were 
not typical in trial 1 for the control and antibi-
otic treatments in comparison to previous re-
search conducted within our laboratory.  Rea-
sons for the underperformance of the antim-
icrobial regimen are uncertain in the presence 
of an enteric pathogen.  However, trial 2 
showed all treatments having improved per-
formance over the control diet.  Trial 2 also 
showed the expected growth enhancement 
properties of carbadox in the presence of en-
teric disease.  Although not significant, Bio-
plus 2B and Levucell showed improvement 
over the control with about a 10% improve-
ment in growth and 7% improvement in feed 
intake.  The combination treatment showed 
only a 7% improvement in growth over the 
control in trial 2.  These, diets containing Bio-
plus 2B or Levucell SB in a production envi-
ronment may provide improved growth en-
hancement over diets with no antimicrobials 
in the presence of an enteric pathogen. 
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Figure 1.  Effect of BioPlus 2B and Levucell SB on growth performance of weaned pigs 
prior to and after oral challenge with 106 Salmonella Serovar Typhimurium on d 14 in 
both trials. The number of pens per treatment is given in parenthesis in the figure legends. 
Within period bars with different superscripts differ (P< 0.05). 
 
